The molecular basis for oat intolerance in patients with celiac disease
Helene Arentz-Hansen, Burkhard Fleckenstein, Øyvind Molberg, Helge Scott, Frits Koning, Günther Jung, Peter Roepstorff, Knut E A Lundin, Ludvig M Sollid, Helene Arentz-Hansen, Burkhard Fleckenstein, Øyvind Molberg, Helge Scott, Frits Koning, Günther Jung, Peter Roepstorff, Knut E A Lundin, Ludvig M Sollid
Abstract
Background: Celiac disease is a small intestinal inflammatory disorder characterized by malabsorption, nutrient deficiency, and a range of clinical manifestations. It is caused by an inappropriate immune response to dietary gluten and is treated with a gluten-free diet. Recent feeding studies have indicated oats to be safe for celiac disease patients, and oats are now often included in the celiac disease diet. This study aimed to investigate whether oat intolerance exists in celiac disease and to characterize the cells and processes underlying this intolerance.
Methods and findings: We selected for study nine adults with celiac disease who had a history of oats exposure. Four of the patients had clinical symptoms on an oats-containing diet, and three of these four patients had intestinal inflammation typical of celiac disease at the time of oats exposure. We established oats-avenin-specific and -reactive intestinal T-cell lines from these three patients, as well as from two other patients who appeared to tolerate oats. The avenin-reactive T-cell lines recognized avenin peptides in the context of HLA-DQ2. These peptides have sequences rich in proline and glutamine residues closely resembling wheat gluten epitopes. Deamidation (glutamine-->glutamic acid conversion) by tissue transglutaminase was involved in the avenin epitope formation.
Conclusions: We conclude that some celiac disease patients have avenin-reactive mucosal T-cells that can cause mucosal inflammation. Oat intolerance may be a reason for villous atrophy and inflammation in patients with celiac disease who are eating oats but otherwise are adhering to a strict gluten-free diet. Clinical follow-up of celiac disease patients eating oats is advisable.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist. LMS is a member of the editorial board of PLoS Medicine.
Figures
References
- Sollid LM. Coeliac disease: Dissecting a complex inflammatory disorder. Nat Rev Immunol. 2002;2:647–655.
- Janatuinen EK, Pikkarainen PH, Kemppainen TA, Kosma VM, Jarvinen RM, et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med. 1995;333:1033–1037.
- Srinivasan U, Leonard N, Jones E, Kasarda DD, Weir DG, et al. Absence of oats toxicity in adult coeliac disease. BMJ. 1996;313:1300–1301.
- Hardman CM, Garioch JJ, Leonard JN, Thomas HJ, Walker MM, et al. Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med. 1997;337:1884–1887.
- Reunala T, Collin P, Holm K, Pikkarainen P, Miettinen A, et al. Tolerance to oats in dermatitis herpetiformis. Gut. 1998;43:490–493.
- Hoffenberg EJ, Haas J, Drescher A, Barnhurst R, Osberg I, et al. A trial of oats in children with newly diagnosed celiac disease. J Pediatr. 2000;137:361–366.
- Janatuinen EK, Kemppainen TA, Julkunen RJ, Kosma VM, Maki M, et al. No harm from five year ingestion of oats in coeliac disease. Gut. 2002;50:332–335.
- Størsrud S, Olsson M, Arvidsson LR, Nilsson LA, Nilsson O, et al. Adult coeliac patients do tolerate large amounts of oats. Eur J Clin Nutr. 2003;57:163–169.
- Högberg L, Laurin P, Fälth-Magnusson K, Grant C, Grodzinsky E, et al. Oats to children with newly diagnosed coeliac disease: A randomised double blind study. Gut. 2004;53:649–654.
- Kilmartin C, Lynch S, Abuzakouk M, Wieser H, Feighery C. Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture. Gut. 2003;52:47–52.
- Vader LW, de Ru A, van Der WY, Kooy YM, Benckhuijsen W, et al. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med. 2002;195:643–649.
- Piper JL, Gray GM, Khosla C. High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: Implications for celiac sprue. Biochemistry. 2002;41:386–393.
- Thompson T. Oats and the gluten-free diet. J Am Diet Assoc. 2003;103:376–379.
- Peräaho M, Kaukinen K, Mustalahti K, Vuolteenaho N, Mäki M, et al. Effect of an oats-containing gluten-free diet on symptoms and quality of life in coeliac disease. A randomized study. Scand J Gastroenterol. 2004;39:27–31.
- Lundin KEA, Nilsen EM, Scott HG, Løberg EM, Gjøen A, et al. Oats induced villous atrophy in coeliac disease. Gut. 2003;52:1149–1152.
- Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: Time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185–1194.
- Molberg Ø, Flaete NS, Jensen T, Lundin KEA, Arentz-Hansen H, et al. Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology. 2003;125:337–344.
- Roepstorff P, Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed Mass Spectrom. 1984;11:601.
- Fleckenstein B, Molberg Ø, Qiao SW, Schmid DG, von der Mulbe F, et al. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. J Biol Chem. 2002;277:34109–34116.
- Arentz-Hansen H, Körner R, Molberg Ø, Quarsten H, Vader W, et al. The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med. 2000;191:603–612.
- Kim CY, Quarsten H, Bergseng E, Khosla C, Sollid LM. Structural basis for HLA-DQ2 mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A. 2004;101:4175–4179.
- Vader LW, Stepniak DT, Bunnik EM, Kooy YMC, de Haan W, et al. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology. 2003;125:1105–1113.
- Arentz-Hansen H, McAdam SN, Molberg Ø, Fleckenstein B, Lundin KEA, et al. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology. 2002;123:803–809.
- Shan L, Molberg Ø, Parrot I, Hausch F, Filiz F, et al. Structural basis for gluten intolerance in celiac sprue. Science. 2002;297:2275–2279.
- Shewry PR, Tatham AS, Kasarda DD. Cereal proteins and coeliac disease. In: Marsh M, editor. Coeliac disease. Oxford: Blackwell Scientific Publications; 1992. pp. 305–348.
- Lundin KEA, Scott H, Fausa O, Thorsby E, Sollid LM. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol. 1994;41:285–291.
Source: PubMed